Clinician-Patient Biological Binding
by Nick Clark | Published April 25, 2026
Clinical decision authorship needs structural binding between the clinician and the medical action. Continuity-based identity supports cockpit-voice-recorder-equivalent attestation for medical autonomous-decision-making — the audit-grade binding that medical-device regulation increasingly demands.
What Clinician-Patient Binding Specifies
Medical decisions in autonomous and semi-autonomous clinical systems require attribution to the responsible clinician. The clinician's authority over the decision must be structurally recorded with audit-grade lineage. Continuity-based clinician binding provides this: the clinician's biological-continuity attestation binds to the medical action through a credentialed observation; the binding is continuously re-validated; the lineage records the clinical action with the clinician's binding context.
The architecture handles patterns specific to clinical operation: clinician shift change with patient handoff, multi-disciplinary care where multiple clinicians have binding authority over different aspects of patient care, emergency-assumption when a primary clinician is unavailable, supervisor-trainee binding patterns where the supervisor's authority backs the trainee's actions.
Why Clinical Decision Attribution Has Structural Gaps
Current clinical-decision-attribution mechanisms (electronic health record entries with the clinician's login, prescriber identifiers on orders, signing-clinician fields on procedure notes) provide attribution but not continuous binding. The clinician was logged in when the action was attributed; subsequent actions until logout are attributed to the same clinician regardless of whether the clinician was actually present.
FDA's evolving framework for AI/ML SaMD increasingly emphasizes provenance: which clinician supervised this AI-assisted decision, with what authority, under what binding state. The architectural primitive provides the structural support that the regulatory framework is converging toward. Without it, regulated AI-assisted clinical decision-support faces compliance challenges that current architecture handles through reconstruction.
How Clinician Binding Composes With Clinical Operations
Each clinician carries credentialed biological-continuity attestation through facility-issued wearable or personal device. When the clinician enters a patient-care context (room, OR, ICU bay), the binding observation is created (clinician's continuity + patient's identity + the binding event signed by the facility's authority). Mesh-broadcast of binding status keeps the clinical operational system informed.
Clinical actions during the binding's nominal status are attributed to the clinician with audit-grade lineage. Status transitions (clinician steps away, fatigue detected, shift change) produce credentialed observations that the operational system coordinates response around. Multi-clinician scenarios (consulting specialist, supervising attending, multidisciplinary team) produce composite binding observations that capture the actual authority structure.
What This Enables for Medical Autonomy Compliance
FDA AI/ML SaMD compliance gains structural clinician-binding lineage. The regulatory question 'who supervised this AI-assisted decision' has architecturally-supported answers rather than reconstructed ones. The compliance pathway maps directly to the architectural primitive.
Medical-malpractice litigation and insurance frameworks gain the same architectural foundation. The structural binding provides evidence that current EHR attribution doesn't structurally support. The patent positions the primitive at the layer where medical autonomy attribution has been operating without architectural support beyond per-EHR custom attribution mechanisms.
